BBMUX
Price
$9.83
Change
-$0.03 (-0.30%)
Updated
Jan 10 closing price
Net Assets
15.93B
DITEX
Price
$12.55
Change
-$0.04 (-0.32%)
Updated
Jan 10 closing price
Net Assets
379.23M
Ad is loading...

BBMUX vs DITEX

Header iconBBMUX vs DITEX Comparison
Open Charts BBMUX vs DITEXBanner chart's image
Bridge Builder Municipal Bond
Price$9.83
Change-$0.03 (-0.30%)
VolumeN/A
Net Assets15.93B
BNY Mellon Intermediate Municipal Bond
Price$12.55
Change-$0.04 (-0.32%)
VolumeN/A
Net Assets379.23M
BBMUX vs DITEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BBMUX vs. DITEX commentary
Jan 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBMUX is a Hold and DITEX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
BBMUX has more cash in the bank: 15.9B vs. DITEX (379M). BBMUX pays higher dividends than DITEX: BBMUX (3.06) vs DITEX (2.39). BBMUX was incepted earlier than DITEX: BBMUX (9 years) vs DITEX (41 years). BBMUX is a more actively managed with annual turnover of: 26.00 vs. DITEX (14.58). BBMUX has a lower initial minimum investment than DITEX: BBMUX (0) vs DITEX (2500). BBMUX annual gain was more profitable for investors over the last year : 1.78 vs. DITEX (0.73). BBMUX return over 5 years is better than : 5.65 vs. DITEX (1.57).
BBMUXDITEXBBMUX / DITEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years41 years-
Gain YTD-0.405-0.397102%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets15.9B379M4,195%
Annual Yield % from dividends3.062.39128%
Returns for 1 year1.780.73245%
Returns for 3 years0.57-1.30-44%
Returns for 5 years5.651.57360%
Returns for 10 yearsN/A12.07-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ABTS0.45N/A
+0.81%
Abits Group
JWN24.01-0.08
-0.33%
Nordstrom
ARES175.04-7.26
-3.98%
Ares Management Corp
CRDF3.61-0.30
-7.55%
Cardiff Oncology
NTLA10.20-1.82
-15.14%
Intellia Therapeutics